Intracellular Nogo-A facilitates initiation of neurite formation in mouse midbrain neurons in vitro

Neuroscience

Volumn 256, Issue , 2014, Pages 456-466

  Kurowska, Z ^a   Brundin, P ^a,b   Schwab, M E ^c   Li, J Y ^a  

^a LUND UNIVERSITY   (Sweden)

^b VAN ANDEL RESEARCH INSTITUTE   (United States)

^c University of Zurich Brain Research Institute   (Switzerland)

Author keywords

Cell culture; Midbrain dopaminergic neurons; Neurite growth; Nogo A; Parkinson's disease

Indexed keywords

DOPAMINE; NEUTRALIZING ANTIBODY; OXIDOPAMINE; PROTEIN NOGO A; TYROSINE 3 MONOOXYGENASE; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIBODY; MYELIN PROTEIN; PROTEIN NOGO;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL MATURATION; CELL MEMBRANE; CELL REGENERATION; CELL SURVIVAL; DOPAMINERGIC NERVE CELL; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MESENCEPHALON; MOUSE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEWBORN; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; UPREGULATION; WILD TYPE; AGE; ANIMAL; CORPUS STRIATUM; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MAMMALIAN EMBRYO; METABOLISM; NERVE CELL; NEURITE; ORGAN CULTURE TECHNIQUE; PHYSIOLOGY; TRANSFORMED CELL LINE; TUMOR CELL LINE;

ADRENERGIC AGENTS; AGE FACTORS; ANIMALS; ANTIBODIES; CELL COUNT; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CORPUS STRIATUM; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION; HUMANS; MESENCEPHALON; MICE; MICE, KNOCKOUT; MYELIN PROTEINS; NEURITES; NEURONS; ORGAN CULTURE TECHNIQUES; OXIDOPAMINE;

EID: 84890022817     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.10.029     Document Type: Article

References (48)

1. Bandtlow C.E., Dlaska M., Pirker S., Czech T., Baumgartner C., Sperk G. Increased expression of Nogo-A in hippocampal neurons of patients with temporal lobe epilepsy. Eur J Neurosci 2004, 20:195-206.
2. Bossers K., Meerhoff G., Balesar R., van Dongen J.W., Kruse C.G., Swaab D.F., Verhaagen J. Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death. Brain Pathol 2009, 19:91-107.
3. Buss A., Sellhaus B., Wolmsley A., Noth J., Schwab M.E., Brook G.A. Expression pattern of NOGO-A protein in the human nervous system. Acta Neuropathol 2005, 110:113-119.
4. Caroni P., Schwab M.E. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1988, 1:85-96.
5. Chen M.S., Huber A.B., van der Haar M.E., Frank M., Schnell L., Spillmann A.A., Christ F., Schwab M.E. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000, 403:434-439.
6. Choi H.K., Won L., Roback J.D., Wainer B.H., Heller A. Specific modulation of dopamine expression in neuronal hybrid cells by primary cells from different brain regions. Proc Natl Acad Sci U S A 1992, 89:8943-8947.
7. Choi H.K., Won L.A., Kontur P.J., Hammond D.N., Fox A.P., Wainer B.H., Hoffmann P.C., Heller A. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res 1991, 552:67-76.
8. Chu Y., Kompoliti K., Cochran E.J., Mufson E.J., Kordower J.H. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J Comp Neurol 2002, 450:203-214.
9. Delekate A., Zagrebelsky M., Kramer S., Schwab M.E., Korte M. NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc Natl Acad Sci U S A 2011, 108:2569-2574.
10. Dimou L., Schnell L., Montani L., Duncan C., Simonen M., Schneider R., Liebscher T., Gullo M., Schwab M.E. Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci 2006, 26:5591-5603.
11. Dodd D.A., Niederoest B., Bloechlinger S., Dupuis L., Loeffler J.P., Schwab M.E. Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J Biol Chem 2005, 280:12494-12502.
12. Emborg M.E., Ma S.Y., Mufson E.J., Levey A.I., Taylor M.D., Brown W.D., Holden J.E., Kordower J.H. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys. J Comp Neurol 1998, 401:253-265.
13. Fournier A.E., Takizawa B.T., Strittmatter S.M. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 2003, 23:1416-1423.
14. Hamza T.H., Zabetian C.P., Tenesa A., Laederach A., Montimurro J., Yearout D., Kay D.M., Doheny K.F., Paschall J., Pugh E., Kusel V.I., Collura R., Roberts J., Griffith A., Samii A., Scott W.K., Nutt J., Factor S.A., Payami H. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature genetics 2010, 42:781-785.
15. Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function. Pharmacol Rev 1966, 18:925-964.
16. Huber A.B., Weinmann O., Brosamle C., Oertle T., Schwab M.E. Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci 2002, 22:3553-3567.
17. Hunt D., Coffin R.S., Prinjha R.K., Campbell G., Anderson P.N. Nogo-A expression in the intact and injured nervous system. Mol Cell Neurosci 2003, 24:1083-1102.
18. Ivanova T., Beyer C. Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. J Neurobiol 2003, 54:638-647.
19. Kapfhammer J.P., Schwab M.E. Inverse patterns of myelination and GAP-43 expression in the adult CNS: neurite growth inhibitors as regulators of neuronal plasticity?. J Comp Neurol 1994, 340:194-206.
20. Kempf A, Montani L, Petrinovic MM, Schroeter A, Weinmann O, Patrignani A, Schwab ME (2013) Upregulation of axon guidance molecules in the adult CNS of Nogo-A KO mice restricts neuronal growth and regeneration. Eur J Neurosci, in press. [Epub ahead of print].
21. Lackner P., Beer R., Broessner G., Helbok R., Dallago K., Hess M.W., Pfaller K., Bandtlow C., Schmutzhard E. Nogo-A expression in the brain of mice with cerebral malaria. PLoS One 2011, 6:e25728.
22. Lesnick T.G., Papapetropoulos S., Mash D.C., Ffrench-Mullen J., Shehadeh L., de Andrade M., Henley J.R., Rocca W.A., Ahlskog J.E., Maraganore D.M. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet 2007, 3:e98.
23. Lotharius J., Barg S., Wiekop P., Lundberg C., Raymon H.K., Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J Biol Chem 2002, 277:38884-38894.
24. Lotharius J., Falsig J., van Beek J., Payne S., Dringen R., Brundin P., Leist M. Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. J Neurosci 2005, 25:6329-6342.
25. Mathis C., Schroter A., Thallmair M., Schwab M.E. Nogo-a regulates neural precursor migration in the embryonic mouse cortex. Cereb Cortex 2010, 20:2380-2390.
26. Maxwell S.L., Ho H.Y., Kuehner E., Zhao S., Li M. Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development. Dev Biol 2005, 282:467-479.
27. McGee A.W., Yang Y., Fischer Q.S., Daw N.W., Strittmatter S.M. Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science 2005, 309:2222-2226.
28. Mingorance-Le Meur A., Zheng B., Soriano E., del Rio J.A. Involvement of the myelin-associated inhibitor Nogo-A in early cortical development and neuronal maturation. Cereb Cortex 2007, 17:2375-2386.
29. Montani L., Gerrits B., Gehrig P., Kempf A., Dimou L., Wollscheid B., Schwab M.E. Neuronal Nogo-A modulates growth cone motility via Rho-GTP/LIMK1/cofilin in the unlesioned adult nervous system. J Biol Chem 2009, 284:10793-10807.
30. Oertle T., van der Haar M.E., Bandtlow C.E., Robeva A., Burfeind P., Buss A., Huber A.B., Simonen M., Schnell L., Brosamle C., Kaupmann K., Vallon R., Schwab M.E. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 2003, 23:5393-5406.
31. Pernet V., Joly S., Dalkara D., Schwarz O., Christ F., Schaffer D., Flannery J.G., Schwab M.E. Neuronal Nogo-A upregulation does not contribute to ER stress-associated apoptosis but participates in the regenerative response in the axotomized adult retina. Cell Death Differ 2012, 19:1096-1108.
32. Petrinovic M.M., Duncan C.S., Bourikas D., Weinman O., Montani L., Schroeter A., Maerki D., Sommer L., Stoeckli E.T., Schwab M.E. Neuronal Nogo-A regulates neurite fasciculation, branching and extension in the developing nervous system. Development 2010, 137:2539-2550.
33. Petrinovic M.M., Hourez R., Aloy E.M., Dewarrat G., Gall D., Weinmann O., Gaudias J., Bachmann L.C., Schiffmann S.N., Vogt K.E., Schwab M.E. Neuronal Nogo-A negatively regulates dendritic morphology and synaptic transmission in the cerebellum. Proc Natl Acad Sci U S A 2013, 110:1083-1088.
34. Pruszak J, Just L, Isacson O, Nikkhah G (2009) Isolation and culture of ventral mesencephalic precursor cells and dopaminergic neurons from rodent brains. Curr Protoc Stem Cell Biol [Chapter 2:Unit 2D 5], Wiley Online Library.
35. Raiker S.J., Lee H., Baldwin K.T., Duan Y., Shrager P., Giger R.J. Oligodendrocyte-myelin glycoprotein and Nogo negatively regulate activity-dependent synaptic plasticity. J Neurosci 2010, 30:12432-12445.
36. Richard M., Giannetti N., Saucier D., Sacquet J., Jourdan F., Pellier-Monnin V. Neuronal expression of Nogo-A mRNA and protein during neurite outgrowth in the developing rat olfactory system. Eur J Neurosci 2005, 22:2145-2158.
37. Rick C.E., Ebert A., Virag T., Bohn M.C., Surmeier D.J. Differentiated dopaminergic MN9D cells only partially recapitulate the electrophysiological properties of midbrain dopaminergic neurons. Dev Neurosci 2006, 28:528-537.
38. Riederer P., Wuketich S. Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 1976, 38:277-301.
39. Schildknecht S., Poltl D., Nagel D.M., Matt F., Scholz D., Lotharius J., Schmieg N., Salvo-Vargas A., Leist M. Requirement of a dopaminergic neuronal phenotype for toxicity of low concentrations of 1-methyl-4-phenylpyridinium to human cells. Toxicol Appl Pharmacol 2009, 241:23-35.
40. Scholz D., Poltl D., Genewsky A., Weng M., Waldmann T., Schildknecht S., Leist M. Rapid, complete and large-scale generation of post-mitotic neurons from the human LUHMES cell line. J Neurochem 2011, 119:957-971.
41. Schwab M.E. Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci 2010, 11:799-811.
42. Simonen M., Pedersen V., Weinmann O., Schnell L., Buss A., Ledermann B., Christ F., Sansig G., van der Putten H., Schwab M.E. Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron 2003, 38:201-211.
43. Tews B., Schonig K., Arzt M.E., Clementi S., Rioult-Pedotti M.S., Zemmar A., Berger S.M., Schneider M., Enkel T., Weinmann O., Kasper H., Schwab M.E., Bartsch D. Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc Natl Acad Sci U S A 2013, 110:6583-6588.
44. Tozaki H., Kawasaki T., Takagi Y., Hirata T. Expression of Nogo protein by growing axons in the developing nervous system. Brain Res Mol Brain Res 2002, 104:111-119.
45. Wang X., Chun S.J., Treloar H., Vartanian T., Greer C.A., Strittmatter S.M. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 2002, 22:5505-5515.
46. Yiu G., He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 2006, 7:617-627.
47. Zagrebelsky M., Schweigreiter R., Bandtlow C.E., Schwab M.E., Korte M. Nogo-A stabilizes the architecture of hippocampal neurons. J Neurosci 2010, 30:13220-13234.
48. Zhou Q.Y., Quaife C.J., Palmiter R.D. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development. Nature 1995, 374:640-643.